VANCOUVER, BC, Sept. 25, 2023 /PRNewswire/ – In the relentless battle against the ever-evolving COVID-19 pandemic, Gene Bio Medical (GBM), a leading player in the field of medical innovations, is taking center stage with its remarkable contribution. GBM's SwiftSwab Antigen Test Kit has emerged as a powerful tool in containing the transmission of the new COVID-19 variants, especially during these crucial times.
The SwiftSwab Antigen Test Kit is not only instrumental in detecting COVID-19 variants but also in addressing the long-term impacts of Long COVID, which continue to affect individuals even after recovery from the acute phase of the illness. By providing early and accurate detection, SwiftSwab contributes to better understanding and management of Long COVID.
SwiftSwab proudly represents Canadian innovation and contributes to the resilience of the country's medical supply chain. Developed in Canada, it embodies the nation's commitment to self-reliance in the face of healthcare challenges.
Health Canada's recognition of SwiftSwab underscores its safety and effectiveness. The product's availability in independent pharmacies across Canada ensures that it reaches a wide audience, bolstering the country's response to the ongoing pandemic.
SwiftSwab isn't just about early detection; it is also affordable and efficient. This makes it an accessible solution for individuals and families across Canada, ensuring that everyone has access to reliable COVID-19 testing.
The SwiftSwab Antigen Test Kit, a pioneering creation by GBM, has showcased its exceptional ability to detect more than 40 distinct COVID-19 variants, including seven highly infectious SARS-CoV-2 strains. With the Centers for Disease Control and Prevention (CDC) reporting a surge in COVID-19 cases and hospitalizations, the importance of continuous testing and early detection cannot be overstated.
The ongoing challenge posed by the Omicron variant, along with its sub-variants such as EG.5 and BA.2.86, demands unwavering attention on a global scale. The EG.5 variant, akin to XBB variants, carries a mutation that can resist some acquired immunity and exhibits a rapid growth advantage, establishing its dominance in many regions. The prevalence of EG.5 in the United States is predicted to rise significantly.
In a world where over 30,000 COVID-19 Antigen mutant strains have been reported, Gene Bio Medical underscores the importance of constant monitoring and research into these strains. Specific mutations in the Spike protein's receptor-binding domain (RBD) could potentially enhance the virus's transmissibility and virulence.
A recent study conducted by the Belgium Department of Laboratory Medicine and Department of Pharmacy has highlighted GBM's SwiftSwab Antigen Self Test as a standout product in detecting both Omicron and Delta variants. The test has demonstrated superior performance compared to other widely used COVID-19 Antigen detection reagents.
GBM's SwiftSwab Antigen Self Test is readily available for purchase, offering a rapid and accurate defense against COVID-19 and its variants. As the world collectively navigates this pandemic, GBM urges all stakeholders to adhere to long-term recommendations and foster global collaboration, emphasizing the critical steps required to overcome this global health crisis.
About Gene Bio Medical (GBM):
Gene Bio Medical (GBM) is a leading innovator in the field of medical technology and diagnostics. With a commitment to advancing healthcare and improving lives, GBM develops cutting-edge solutions for the most pressing global health challenges.
Website: www.genebiomedical.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/gene-bio-medical-gbm-pioneering-the-fight-against-covid-19-variants-with-swiftswab-antigen-test-kit-301938157.html
SOURCE Gene Bio Medical
(Bloomberg) — The US Securities and Exchange Commission said it has concerns about Coinbase Global Inc.’s proposed involvement in Celsius Network’s plan to emerge from bankruptcy.Most Read from BloombergIndians Have Five Days to Deposit $3 Billion in Soon-to-Be-Withdrawn BanknotesDimon Warns World Not Ready for 7% Fed Rate: Times of IndiaCostco Offers Members $29 Online Health Care VisitsIndia-Canada Clash Should Be a Wake-Up CallBonds Sink, S&P 500 Snaps Four-Day Losing Streak: Markets WrapUnd
(Bloomberg) — Twelve states in the US, including some of the country’s largest economies, are at risk of cutting or scaling back programs in essential areas like education and public safety when the federal government’s historic stimulus package expires in 2026. Most Read from BloombergRepublican Moderates Turn to Rare Maneuver to Avoid Lengthy Government ShutdownDimon Warns 7% Fed Rate Still Possible, Times of India SaysIndians Have Five Days to Deposit $3 Billion in Soon-to-Be-Withdrawn Bankn
Soleno said Tuesday its experimental pill helped control hunger signals in a genetic disorder. In response, SLNO stock skyrocketed.
The company's stock soared to close to $80 in March 2021 and it grabbed 84,000 square feet of space in South San Francisco. Two years later, it went fully remote.
The pharmaceuticals sector is enduring a tough year in the stock market. Companies selling weight-loss drugs are a big exception.
The push for antibiotics to fight fast-evolving superbugs is snagging on a broken business model. Six startups have won Food and Drug Administration approval for new antibiotics since 2017. All have filed for bankruptcy, been acquired or are shutting down.
Pfizer, Merck and AstraZeneca are part of the Zacks top Analyst Blog.
AstraZeneca (AZN) announces positive results from the late-stage study evaluating its antibody-drug conjugate, Dato-DXd, in pre-treated patients with HR+/HER2- metastatic breast cancer.
(Bloomberg) — Tesla Inc. Chief Executive Officer Elon Musk blasted the United Auto Workers Tuesday, saying the union’s demands would “drive GM, Ford and Chrysler bankrupt in the fast lane.” Most Read from BloombergChina Puts Evergrande’s Billionaire Founder Under Police ControlDimon Warns 7% Fed Rate Still Possible, Times of India SaysRepublican Moderates Turn to Rare Maneuver to Avoid Lengthy Government ShutdownIndians Have Five Days to Deposit $3 Billion in Soon-to-Be-Withdrawn BanknotesTrump
JPMorgan Chase made millions by keeping Jeffrey Epstein as a banking client. Now it faces a reckoning in federal court.
Stocks have suffered a rough September, with the S&P 500 dropping from 4,516 at the month's start to 4,275. Look out below?
After beginning the year at record levels, global events have caused market volatility to jump and equities to fall. The S&P 500 Index is experiencing its first major correction since 2020, so investors are understandably looking to safeguard their assets. … Continue reading → The post Schwab Says This Can Double Your Retirement Savings appeared first on SmartAsset Blog.
Do you have enough money to retire? There are many different ways to look at this, but the most common is to break it down simply: money in vs. money out. How much income can you generate from your retirement planning, and how much will you need to spend? Here, say that you have $1 […] The post I Have $1 Million in a 401(k) and Will Receive $2,500 Monthly From Social Security. Can I Retire at 65? appeared first on SmartReads by SmartAsset.
Yes, the housing market is cooling. But there’s wide agreement among experts about one thing.
Carnival's (CCL) fiscal third-quarter top line is likely to have benefited from improvements in booking activities, robust pricing environment and capacity-generation initiatives.
After a volatile end to the summer, can investors look forward to a gentler autumn? There is some reason to hope so, according to Sharmin Mossavar-Rahmani, chief investment officer of wealth management at Goldman Sachs. This year, as the S&P 500 rebounded from the 19% loss it sustained in 2022, Mossavar-Rahmani has seen her bullish position vindicated, and she believes recent earnings trends and the receding probability of a recession promise further gains to come. In an interview with Barron’s,
Target expects to lose roughly $1.2 billion in profits from retail theft in 2022 and 2023.
At age 99, Charlie Munger, vice chairman of Berkshire Hathaway Inc. and a Daily Journal board member, is a man many are eager to listen to. People tend to hang on to his every word like gospel. His decades of experience in investing, governance and law have given him a unique perspective on business and life, making his insights invaluable to anyone seeking wisdom. Don’t Miss: Goldman Sachs says: Portfolio(s) with a slice of real assets [like art] performed even better than the 60/40 over the lo
Last year's high-profile divorce between Bill Gates and Melinda Gates made headlines, not only for being one of the most expensive divorces in history — Melinda reportedly walked away with an estimated $70 billion — but also for casting a spotlight on an unusual marital agreement. From the start of their marriage, Gates had Melinda's blessing to continue an annual vacation with his ex-girlfriend Ann Winblad. This arrangement is one many people would find unconventional if not unacceptable. Don’t
Nobody makes enemies like Donald Trump, and his 2024 presidential election campaign promises some interesting new ones. The most recent: electric vehicles.